The effect of Kaposi Sarcoma on mortality and loss to follow-up after initiation of ART among 13,065 adult HIV-infected patients initiating ART in Cape Town and Johannesburg, South Africa.

†HR = hazard ratio, CI = confidence interval, KS = Kaposi sarcoma, ART = antiretroviral therapy, pys = person years, hazard ratios from a Cox proportional hazards regression model.‡Models adjusted for sex, baseline CD4 count, age, treatment site, tuberculosis at ART initiation, year of ART initiation.*pys = person years.**LTFU = Lost to follow up defined as having missed a clinic appointment by at least 3-months after the scheduled visit date.